ID   UBi001-A
AC   CVCL_YM94
SY   WT1-iPS; WT-iPS
DR   BioSamples; SAMEA6298140
DR   hPSCreg; UBi001-A
DR   Wikidata; Q98133807
RX   PubMed=26411903;
RX   PubMed=31731183;
RX   PubMed=31825816;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+WT1-iPS+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/WT1-iPS%2520Anexo%2520I.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 11,13
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 10,13
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
RX   PubMed=26411903; DOI=10.1016/j.stemcr.2015.08.016; PMCID=PMC4625033;
RA   Canals I., Soriano J., Orlandi J.G., Torrent R., Richaud-Patin Y.,
RA   Jimenez-Delgado S., Merlin S., Follenzi A., Consiglio A.,
RA   Vilageliu L., Grinberg D., Raya A.;
RT   "Activity and high-order effective connectivity alterations in
RT   Sanfilippo C patient-specific neuronal networks.";
RL   Stem Cell Reports 5:546-557(2015).
//
RX   PubMed=31731183; DOI=10.1016/j.scr.2019.101616;
RA   Beneto N., Cozar M., Garcia-Morant M., Creus-Bachiller E.,
RA   Vilageliu L., Grinberg D., Canals I.;
RT   "Generation of two compound heterozygous HGSNAT-mutated lines from
RT   healthy induced pluripotent stem cells using CRISPR/Cas9 to model
RT   Sanfilippo C syndrome.";
RL   Stem Cell Res. 41:101616-101616(2019).
//
RX   PubMed=31825816; DOI=10.1016/j.scr.2019.101668;
RA   Beneto N., Cozar M., Gort L., Pacheco L., Vilageliu L., Grinberg D.,
RA   Canals I.;
RT   "Generation of two NAGLU-mutated homozygous cell lines from healthy
RT   induced pluripotent stem cells using CRISPR/Cas9 to model Sanfilippo B
RT   syndrome.";
RL   Stem Cell Res. 42:101668-101668(2020).
//